In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Aclaris Therapeutics Inc’s stock clocked out at $1.23, down -7.52% from its previous closing price of $1.33. In other words, the price has decreased by -$7.52 from its previous closing price. On the day, 0.95 million shares were traded. ACRS stock price reached its highest trading level at $1.42 during the session, while it also had its lowest trading level at $1.2025.
Ratios:
To gain a deeper understanding of ACRS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 3.99. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On December 23, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACRS now has a Market Capitalization of 133022040 and an Enterprise Value of 40090348. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.09 while its Price-to-Book (P/B) ratio in mrq is 0.85. Its current Enterprise Value per Revenue stands at 2.142 whereas that against EBITDA is -0.768.
Stock Price History:
The Beta on a monthly basis for ACRS is 0.53, which has changed by 0.060344815 over the last 52 weeks, in comparison to a change of -0.034466684 over the same period for the S&P500. Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -36.02%, while the 200-Day Moving Average is calculated to be -35.47%.
Shares Statistics:
It appears that ACRS traded 904.36K shares on average per day over the past three months and 693610 shares per day over the past ten days. A total of 107.85M shares are outstanding, with a floating share count of 91.36M. Insiders hold about 15.34% of the company’s shares, while institutions hold 68.58% stake in the company. Shares short for ACRS as of 1741910400 were 6027086 with a Short Ratio of 6.66, compared to 1739491200 on 5023533. Therefore, it implies a Short% of Shares Outstanding of 6027086 and a Short% of Float of 6.68.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
